3-D Matrix, Ltd.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a DMTRF research report →
Price Chart
About the company
3-D Matrix, Ltd. specializes in advancing self-assembling peptide technology. The company's primary offering is PuraMatrix, an innovative self-assembling peptide hydrogel utilized across diverse medical sectors such as regenerative medicine, cell-based therapies, sophisticated drug delivery mechanisms, and various surgical applications.
- CEO
- Toshihiko Amanuma
- IPO
- 2013
- Employees
- 129
- HQ
- Tokyo, TY, JP
Get TickerSpark's AI analysis on DMTRF
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
- Market Cap
- $360.91M
- P/E
- 13.40
- PEG
- 0.00
- P/S
- 4.37
- P/B
- 7.22
- EV/EBITDA
- 20.09
- Div Yield
- 0.00%
- Gross Margin
- 79.52%
- Op Margin
- 15.28%
- Net Margin
- 30.99%
- ROE
- 63.82%
- ROIC
- 23.20%
Latest fiscal year · YoY change
- Revenue
- $10.87B+56.7%
- Gross Profit
- $8.56B+93.4%
- Op Income
- $1.33B
- Net Income
- $4.15B+265.9%
- EPS
- $34.41+236.5%
- OCF Growth
- +123.1%
- FCF Growth
- +121.3%
- 52W High
- $3.96
- 52W Low
- $1.50
- 50D MA
- $2.53
- 200D MA
- $2.89
- Beta
- 0.99
- RSI (14)
- 99
- Avg Volume
- 127
No earnings-call transcripts are available for DMTRF yet.
- Free Float
- 92.3%
- Shares Outstanding
- 127.98M
- Float Shares
- 118.17M
Our DMTRF coverage
Recent articles, reports, and earnings notes.
No research on DMTRF yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate DMTRF report →